HomeALT • NASDAQ
add
Altimmune Inc
Previous close
$8.40
Day range
$8.28 - $8.84
Year range
$2.50 - $14.84
Market cap
617.26M USD
Avg Volume
3.41M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 5.00K | -98.62% |
Operating expense | 4.97M | 10.08% |
Net income | -22.84M | -10.52% |
Net profit margin | -456.90K | -7,901.44% |
Earnings per share | -0.32 | 17.95% |
EBITDA | -24.73M | -10.31% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 139.38M | -0.99% |
Total assets | 147.86M | -11.23% |
Total liabilities | 14.49M | -10.44% |
Total equity | 133.38M | — |
Shares outstanding | 71.12M | — |
Price to book | 4.47 | — |
Return on assets | -38.55% | — |
Return on capital | -42.77% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -22.84M | -10.52% |
Cash from operations | -27.12M | -32.37% |
Cash from investing | 1.20M | -72.76% |
Cash from financing | 266.00K | -54.76% |
Net change in cash | -25.65M | -65.54% |
Free cash flow | -18.95M | -34.13% |
About
Founded
1997
Headquarters
Website
Employees
59